News Focus
News Focus
Replies to #79270 on Biotech Values
icon url

DewDiligence

06/08/09 11:00 PM

#79271 RE: mcbio #79270

Unlike HIV, where entry inhibitors (PFE’s Selzentry, Roche’s Fuzeon) are on the market, entry inhibitors for HCV have a long way to go. I’m almost certain GILD is working on one, although GILD has never stated this explicitly.